SIRT3 and neoplasm: Meanwhile, the HIF-1α/ROS regulatory axis couples the SIRT3- and SIRT6-driven metabolic reprogramming to oxidative adaptation and glycolytic flexibility, enabling tumor cells to maintain mitochondrial function and survive cytotoxic insults (211, 214).